Vista protein in MS: a blood study
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at a protein called Vista in blood cells of people with multiple sclerosis. Your blood sample will help researchers understand how this protein relates to MS activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older and diagnosed with MS or a first attack (CIS) using the 2017 McDonald criteria
- No other autoimmune disease or cancer now or within the past year
- No antibiotics, NSAIDs (like ibuprofen), or steroids in the last month
- No vaccines in the last month
- For women: not currently on your period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures levels of a protein called VISTA in the blood of people with memory problems caused by blood vessel disease. It aims to see if VISTA can help diagnose or predict this condition.
This study looks at genetic information and blood test signals to understand why some people with early MS develop a worse outcome. It may help doctors predict who is at higher risk and better understand disease mechanisms.
This trial tests an experimental oral drug called VT7208 in both healthy volunteers and people with multiple sclerosis (MS). The goal is to see if it is safe and how the body processes it, which could lead to a new treatment option for MS.
This study measures specific proteins in your blood that may help doctors understand how progressive multiple sclerosis advances. By tracking these markers over time, researchers hope to better predict disease progression and improve treatment decisions.
This study looks at different immune cells in blood and, sometimes, spinal fluid (CSF) to understand what’s driving multiple sclerosis (MS) or early MS-like symptoms. Your participation may help researchers better explain the disease and potentially improve how it’s diagnosed or treated.
This study looks at how “iron rims” in brain MRI scans change over time in people with multiple sclerosis (MS). It may help researchers understand MS activity better and how iron changes relate to disease progression.
Hear when a new Multiple Sclerosis, MS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.